Method for nucleic acid detection by guiding through a nanopore

US11085078B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11085078-B2
Application numberUS-201716338399-A
CountryUS
Kind codeB2
Filing dateSep 29, 2017
Priority dateSep 29, 2016
Publication dateAug 10, 2021
Grant dateAug 10, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a method of detecting a target polynucleotide in a sample comprising: (a) contacting the sample with a guide polynucleotide that binds to a sequence in the target polynucleotide and a polynucleotide-guided effector protein, wherein the guide polynucleotide and polynucleotide-guided effector protein form a complex with any target polynucleotide present in the sample; (b) contacting the sample with a membrane comprising a transmembrane pore; (c) applying a potential to the membrane; and (d) monitoring for the presence or absence of an effect resulting from the interaction of the complex with the transmembrane pore to determine the presence or absence of the complex, thereby detecting the target polynucleotide in the sample.

First claim

Opening claim text (preview).

The invention claimed is: 1. A system for detecting a target polynucleotide in a sample comprising: (i) a nanopore; (ii) an RNA-guided effector protein comprising a guide-RNA binding domain; and (iii) a guide-RNA comprising a crRNA that is complementary to a sequence in the target polynucleotide to be detected and a tracrRNA that is complementary to a sequence in the guide-RNA binding domain of the RNA-guided effector protein, wherein the guide RNA or the RNA-guided effector protein further comprises an adaptor comprising a leader sequence or an anchor capable of coupling to a membrane. 2. The system of claim 1 , further comprising a target polynucleotide and a membrane, wherein the nanopore is present in the membrane. 3. The system of claim 1 , wherein the target polynucleotide, guide-RNA and RNA-guided effector protein form a complex. 4. The system of claim 1 , wherein the target polynucleotide is coupled to a surface. 5. The system of claim 1 , wherein the crRNA and tracrRNA are present in a single guide-RNA. 6. The system according to claim 1 wherein (i) the anchor or (ii) the adaptor is present at the 5′ end of the tracrRNA, the 3′ end of the tracrRNA, the 3′ end of the crRNA, or when the tracrRNA and crRNA are comprised in a sgRNA, the 3′ end of the sgRNA or internally. 7. The system according to claim 1 wherein the anchor is hydrophobic. 8. The system according to claim 1 , wherein the RNA-guided effector protein is a RNA-guided endonuclease or a RNA-guided endonuclease wherein the nuclease activity of the RNA-guided endonuclease is disabled. 9. The system according to claim 1 , wherein one or more of the catalytic nuclease sites of the RNA-guided endonuclease are inactivated. 10. The system according to claim 1 , wherein the RNA-guided effector protein is Cas, Cas12a or Cas13a. 11. The system according to claim 1 , wherein the RNA-guided effector protein is Cas9. 12. A system according to claim 1 , wherein the target polynucleotide is double stranded or comprises a double stranded region and is DNA, a DNA/RNA hybrid or RNA. 13. A system according to claim 1 , wherein the adaptor further comprises a barcode sequence.

Assignees

Inventors

Classifications

  • involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

  • C12Q1/6869Primary

    Methods for sequencing · CPC title

  • Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68) · CPC title

  • Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11085078B2 cover?
The invention provides a method of detecting a target polynucleotide in a sample comprising: (a) contacting the sample with a guide polynucleotide that binds to a sequence in the target polynucleotide and a polynucleotide-guided effector protein, wherein the guide polynucleotide and polynucleotide-guided effector protein form a complex with any target polynucleotide present in the sample; (b) c…
Who is the assignee on this patent?
Oxford Nanopore Tech Ltd
What technology area does this patent fall under?
Primary CPC classification C12Q1/6869. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).